Literature DB >> 12655837

Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men.

P N Halkitis1, J T Parsons, R J Wolitski, R H Remien.   

Abstract

Data regarding HIV antiretroviral treatment regimens, access to treatment and medical care, and adherence to medications were collected as part of the Seropositive Urban Men's Study, a formative study of HIV-positive men who have sex with men. Participants (N = 456) were recruited from AIDS service organizations, mainstream gay venues and public/commercial sex environments. The sample was 94% gay or bisexually-identified; 29% were African American, 24% Latino and 30% white. The majority (71%) indicated being on antiretroviral treatment, and most were taking a protease inhibitor/nucleoside reverse transcriptase inhibitor combination. African American men in New York City were less likely to be on treatment. Among those on treatment (n = 322), 51% reported at least one day in which they had missed a dose of their medication and the mean number of days in which a dose was missed (in the past 30 days) was 1.72. Multivariate analyses indicated that avoidant coping, frequency of drinking alcohol and difficulty in communicating with sex partners about HIV were related to days of missed doses, suggesting the need or desire to escape from the reality of life with HIV as a potential explanation for poor adherence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12655837     DOI: 10.1080/095401221000039798

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  31 in total

1.  The role of multiple identities in adherence to medical appointments among gay/bisexual male adolescents living with HIV.

Authors:  Gary W Harper; Isabel M Fernandez; Douglas Bruce; Sybil G Hosek; Robin J Jacobs
Journal:  AIDS Behav       Date:  2013-01

2.  Racial/Ethnic disparities in ART adherence in the United States: findings from the MACH14 study.

Authors:  Jane M Simoni; David Huh; Ira B Wilson; Jie Shen; Kathy Goggin; Nancy R Reynolds; Robert H Remien; Marc I Rosen; David R Bangsberg; Honghu Liu
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-15       Impact factor: 3.731

Review 3.  Greater risk for HIV infection of black men who have sex with men: a critical literature review.

Authors:  Gregorio A Millett; John L Peterson; Richard J Wolitski; Ron Stall
Journal:  Am J Public Health       Date:  2006-05-02       Impact factor: 9.308

4.  Sero-positive African Americans' beliefs about alcohol and their impact on anti-retroviral adherence.

Authors:  Andrea Sankar; Tracy Wunderlich; Stewart Neufeld; Mark Luborsky
Journal:  AIDS Behav       Date:  2007-03

5.  Stress processes in HIV-positive African American mothers: moderating effects of drug abuse history.

Authors:  Myron J Burns; Daniel J Feaster; Victoria B Mitrani; Christina Ow; José Szapocznik
Journal:  Anxiety Stress Coping       Date:  2008-01

Review 6.  The impact of medication regimen factors on adherence to chronic treatment: a review of literature.

Authors:  Karen S Ingersoll; Jessye Cohen
Journal:  J Behav Med       Date:  2008-01-19

7.  HIV prevention for black men who have sex with men in the United States.

Authors:  John L Peterson; Kenneth T Jones
Journal:  Am J Public Health       Date:  2009-04-16       Impact factor: 9.308

8.  Levels and predictors of HIV risk behavior among Black men who have sex with men.

Authors:  Jeffrey A Kelly; Janet S St Lawrence; Yuri A Amirkhanian; Wayne J DiFranceisco; Michelle Anderson-Lamb; Luis I Garcia; Manh T Nguyen
Journal:  AIDS Educ Prev       Date:  2013-02

9.  What is a missed dose? Implications for construct validity and patient adherence.

Authors:  A P Sankar; D C Nevedal; S Neufeld; M R Luborsky
Journal:  AIDS Care       Date:  2007-07

10.  Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among african american men with HIV.

Authors:  Laura M Bogart; Glenn Wagner; Frank H Galvan; Denedria Banks
Journal:  J Acquir Immune Defic Syndr       Date:  2010-04       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.